IXC 10.5% 6.0¢ invex therapeutics ltd

https://n.neurology.org/content/96/8/e1251#:~:text=A%20recent%20m...

  1. 795 Posts.
    lightbulb Created with Sketch. 45
    https://n.neurology.org/content/96/8/e1251#:~:text=A%20recent%20meta%2Danalysis%20of,of%201.2%2F100%2C000%2Fy.

    you should read this study from Wales, it is another data point which estimates the incidence at 7.8 and prevalence at 75. As far as I understand it, this is very different from Invex's stated numbers, which work on an incidence * 4.3 years to determine prevalence. Whereas, this data from wales would show prevalence = 7.8 * 9.6 years, over double the amount of time with the disease. Could be due to climate or something in Wales, im not sure, but it isn't solely due to obesity
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
-0.007(10.5%)
Mkt cap ! $4.509M
Open High Low Value Volume
6.0¢ 6.0¢ 6.0¢ $3.264K 54.4K

Buyers (Bids)

No. Vol. Price($)
1 600 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 20000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.